Literature DB >> 31452245

circPIP5K1A serves as a competitive endogenous RNA contributing to ovarian cancer progression via regulation of miR-661/IGFBP5 signaling.

Yi Sun1, Xue Li2, Aozheng Chen1, Weihui Shi3, Lei Wang4, Ruhai Yi5, Jin Qiu1.   

Abstract

Increasing evidence demonstrates the crucial regulatory functions of circular RNAs in different cancer types. The major aim of the current study was to establish functions of circPIP5K1A during ovarian cancer. Our results showed an increased expression of circPIP5K1A in both ovarian cancers and cell lines, which was associated with poor prognosis. In functional analyses, downregulation of circPIP5K1A suppressed ovarian cancer cell migration, proliferation, and invasion in vitro. The miR-661 was indicated as a target of circPIP5K1A and insulin-like growth factor-binding protein 5 (IGFBP5) as a target of miR-661. circPIP5K1A silencing triggered downregulation of IGFBP5 through inducing an increase in miR-66 levels, as determined by the luciferase reporter assay. Data from cell counting kit-8, colony formation, wound healing, and Transwell assays showed that overexpression of IGFBP5 effectively reversed the circPIP5K1A depletion effects. The results collectively indicated that circPIP5K1A contributed to ovarian cancer progression via targeting the miR-661/IGFBP5 axis, supporting its utility as a candidate target for therapy of the disease.
© 2019 Wiley Periodicals, Inc.

Entities:  

Keywords:  IGFBP5; circPIP5K1A; invasion; miR-661; ovarian cancer; proliferation

Year:  2019        PMID: 31452245     DOI: 10.1002/jcb.29055

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  14 in total

1.  Exosomal circ_PIP5K1A regulates the progression of non-small cell lung cancer and cisplatin sensitivity by miR-101/ABCC1 axis.

Authors:  Na Shao; Liang Song; Xiaogang Sun
Journal:  Mol Cell Biochem       Date:  2021-02-11       Impact factor: 3.396

2.  CircPDE7B/miR-661 axis accelerates the progression of human keloid fibroblasts by upregulating fibroblast growth factor 2 (FGF2).

Authors:  Fenglian Wu; Hongbin He; Yanxin Chen; Donglai Zhu; Tao Jiang; Jiaxin Wang
Journal:  Mol Cell Biochem       Date:  2022-01-25       Impact factor: 3.396

Review 3.  The emerging roles and potential applications of circular RNAs in ovarian cancer: a comprehensive review.

Authors:  Sajad Najafi
Journal:  J Cancer Res Clin Oncol       Date:  2022-09-02       Impact factor: 4.322

Review 4.  Noncoding RNA actions through IGFs and IGF binding proteins in cancer.

Authors:  Aidan Kerr; Robert C Baxter
Journal:  Oncogene       Date:  2022-05-21       Impact factor: 8.756

5.  CEACAM Gene Family Mutations Associated With Inherited Breast Cancer Risk - A Comparative Oncology Approach to Discovery.

Authors:  Anna L W Huskey; Isaac McNeely; Nancy D Merner
Journal:  Front Genet       Date:  2021-08-10       Impact factor: 4.599

6.  CircRNA PIP5K1A promotes the progression of glioma through upregulation of the TCF12/PI3K/AKT pathway by sponging miR-515-5p.

Authors:  Kebin Zheng; Haipeng Xie; Wensong Wu; Xichao Wen; Zhaomu Zeng; Yanfang Shi
Journal:  Cancer Cell Int       Date:  2021-01-07       Impact factor: 5.722

7.  CircRNAs as potent biomarkers in ovarian cancer: a systematic scoping review.

Authors:  Zahra Foruzandeh; Fatemeh Zeinali-Sehrig; Kazem Nejati; Dara Rahmanpour; Fariba Pashazadeh; Farhad Seif; Mohammad Reza Alivand
Journal:  Cell Mol Biol Lett       Date:  2021-09-23       Impact factor: 5.787

Review 8.  Emerging role of circular RNAs in the pathogenesis of ovarian cancer.

Authors:  Soudeh Ghafouri-Fard; Tayyebeh Khoshbakht; Bashdar Mahmud Hussen; Mohammad Taheri; Majid Samsami
Journal:  Cancer Cell Int       Date:  2022-04-29       Impact factor: 6.429

9.  Blocking circ_0014130 suppressed drug resistance and malignant behaviors of docetaxel resistance-acquired NSCLC cells via regulating miR-545-3p-YAP1 axis.

Authors:  Dongjie Du; Xiaoci Cao; Xinbo Duan; Xianbo Zhang
Journal:  Cytotechnology       Date:  2021-05-25       Impact factor: 2.040

Review 10.  Noncoding RNAs in gastric cancer: implications for drug resistance.

Authors:  Ling Wei; Jujie Sun; Nasha Zhang; Yan Zheng; Xingwu Wang; Liyan Lv; Jiandong Liu; Yeyang Xu; Yue Shen; Ming Yang
Journal:  Mol Cancer       Date:  2020-03-19       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.